Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis

Completed

Conditions studied: Thumb Carpometacarpal Joint Osteoarthritis

In brief

The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma has been demonstrated to be an effective treatment for various musculoskeletal conditions.

Key facts

Study ID

NCT04886349

Run by

Mayo Clinic

People needed

170

Starts

2020-10-01

Expected to finish

2021-04-02

Last updated by the study team

2021-05-14

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who previously underwent PRP injection of their first CMC joint.

You may not qualify if…

• Individuals less than 18 years of age.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.